Integer (NYSE:ITGR) Issues FY 2024 Earnings Guidance

Integer (NYSE:ITGR) updated its FY 2024 earnings guidance on Thursday. The company provided EPS guidance of 5.010-5.430 for the period, compared to the consensus EPS estimate of 5.310. The company issued revenue guidance of $1.7 billion-$1.8 billion, compared to the consensus revenue estimate of $1.8 billion. Integer also updated its FY24 guidance to $5.01-5.43 EPS.

Analyst Upgrades and Downgrades

ITGR has been the subject of several research reports. CL King began coverage on Integer in a report on Thursday, March 14th. They issued a buy rating and a $137.00 target price for the company. Benchmark reaffirmed a buy rating and set a $130.00 price target on shares of Integer in a research report on Friday. Bank of America raised Integer from a neutral rating to a buy rating and increased their price objective for the company from $105.00 to $135.00 in a report on Monday, April 15th. Finally, KeyCorp upped their price target on shares of Integer from $123.00 to $139.00 and gave the company an overweight rating in a research report on Tuesday, April 9th. Three equities research analysts have rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of Moderate Buy and an average target price of $120.50.

Integer Stock Performance

NYSE ITGR traded down $1.56 on Friday, hitting $109.59. 604,251 shares of the company’s stock were exchanged, compared to its average volume of 342,875. The company has a debt-to-equity ratio of 0.64, a current ratio of 2.80 and a quick ratio of 1.71. The firm’s 50-day moving average price is $113.11 and its two-hundred day moving average price is $99.78. The firm has a market cap of $3.67 billion, a price-to-earnings ratio of 40.74, a P/E/G ratio of 1.71 and a beta of 1.10. Integer has a fifty-two week low of $69.40 and a fifty-two week high of $123.99.

Integer (NYSE:ITGR) last released its quarterly earnings data on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.12 by $0.02. The firm had revenue of $414.80 million during the quarter, compared to analysts’ expectations of $412.78 million. Integer had a return on equity of 10.80% and a net margin of 5.68%. Integer’s revenue was up 9.5% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.87 earnings per share. On average, research analysts expect that Integer will post 5.31 EPS for the current year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.